S Li, S Zhuang, A Heit, SL Koo,
AC Tan, IT Chow… - …, 2022 - Taylor & Francis
Tumor-specific T cells likely underpin effective immune checkpoint-blockade therapies. Yet,
most studies focus on Treg cells and CD8+ tumor-infiltrating lymphocytes (TILs). Here, we …